Bruno R - Search Results

1

EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count.

Paolucci S, Cassaniti I, Novazzi F, Fiorina L, Piralla A, Comolli G, Bruno R, Maserati R, Gulminetti R, Novati S, Mojoli F, Baldanti F; San Matteo Pavia COVID-19 Task Force. Paolucci S, et al. Among authors: bruno r. Int J Infect Dis. 2021 Mar;104:315-319. doi: 10.1016/j.ijid.2020.12.051. Epub 2020 Dec 21. Int J Infect Dis. 2021. PMID: 33359064 Free PMC article.

2

Distinct mutational drug resistance profiles of HIV-1 RNA in plasma and culture isolates of patients receiving antiretroviral therapy.

Debiaggi M, Bruno R, Sacchi P, Achilli G, Romero E, Filice G. Debiaggi M, et al. Among authors: bruno r. Intervirology. 2002;45(1):52-5. doi: 10.1159/000050087. Intervirology. 2002. PMID: 11937771

3

Challenges for hepatitis C patients coinfected with HIV.

Bruno R, Cotler S, Sacchi P, Ciappina V, Rondanelli M, Filice G. Bruno R, et al. Am Clin Lab. 2002 Apr;21(3):26-31. Am Clin Lab. 2002. PMID: 12038082 Review. No abstract available.

4

HCV chronic hepatitis in patients with HIV: clinical management issues.

Bruno R, Sacchi P, Puoti M, Soriano V, Filice G. Bruno R, et al. Am J Gastroenterol. 2002 Jul;97(7):1598-606. doi: 10.1111/j.1572-0241.2002.05817.x. Am J Gastroenterol. 2002. PMID: 12135007 Review.

5

Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C.

Bruno R, Sacchi P, Puoti M, Ciappina V, Zocchetti C, Brunetti E, Maffezzini E, Capelli A, Patruno SF, Malfitano A, Filice G. Bruno R, et al. BMC Infect Dis. 2002 Aug 28;2:17. doi: 10.1186/1471-2334-2-17. BMC Infect Dis. 2002. PMID: 12199910 Free PMC article. Clinical Trial.

6

Evaluation of the risk factors associated with lipodystrophy development in a cohort of HIV-positive patients.

Seminari E, Tinelli C, Minoli L, Sacchi P, Filice G, Zocchetti C, Meneghetti G, Bruno R, Maserati R. Seminari E, et al. Among authors: bruno r. Antivir Ther. 2002 Sep;7(3):175-80. Antivir Ther. 2002. PMID: 12487384

7

Overview on the incidence and the characteristics of HIV-related opportunistic infections and neoplasms of the heart: impact of highly active antiretroviral therapy.

Bruno R, Sacchi P, Filice G. Bruno R, et al. AIDS. 2003 Apr;17 Suppl 1:S83-7. doi: 10.1097/00002030-200304001-00012. AIDS. 2003. PMID: 12870535 Review.

8

Host factors affecting the outcome of treatment of hepatitis C.

Bruno R, Sacchi P, Maiocchi L, Zocchetti C, Filice G. Bruno R, et al. Rev Gastroenterol Disord. 2004;4 Suppl 1:S3-7. Rev Gastroenterol Disord. 2004. PMID: 15184818 Review.

9

Dissociation of serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus and treated with antiretroviral drugs.

Furione M, Maserati R, Gatti M, Baldanti F, Cividini A, Bruno R, Gerna G, Mondelli MU. Furione M, et al. Among authors: bruno r. J Clin Microbiol. 2004 Jul;42(7):3012-6. doi: 10.1128/JCM.42.7.3012-3016.2004. J Clin Microbiol. 2004. PMID: 15243052 Free PMC article.

10

Viral dynamics and pharmacokinetics of peginterferon alpha-2a and peginterferon alpha-2b in naive patients with chronic hepatitis c: a randomized, controlled study.

Bruno R, Sacchi P, Ciappina V, Zochetti C, Patruno S, Maiocchi L, Filice G. Bruno R, et al. Antivir Ther. 2004 Aug;9(4):491-7. Antivir Ther. 2004. PMID: 15456079 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,841 results

Search Page

Filters